Remove common-pharma-interest modernizing-therapeutic-cell-production
article thumbnail

Transitioning Between Academia and Industry: Advice from Leading Scientists That Made the Switch

XTalks

To gain insight into the motivations, steps and experiences involved in an academia to industry — or vice versa — transition, Xtalks spoke to several leading scientists and entrepreneurs in pharma and biotech who successfully transitioned from academic positions to leadership roles in industry settings.

article thumbnail

Synthetic biology tools advancing and accelerating drug discovery efforts

Drug Discovery World

“We facilitate parallel DNA synthesis by coupling our chip technology with our re-engineered chemical method that can thermally control DNA synthesis at every single action site on the microchip,” says Dr Michael Daniels, Head of Product Management at Evonetix. . Synthetic libraries for antibody drug discovery .

DNA 98